Literature DB >> 24255889

Evaluation of microvascular reactivity with laser Doppler flowmetry in chronic kidney disease.

Levente Babos1, Zoltán Járai, János Nemcsik.   

Abstract

Cardiovascular diseases are the major causes of mortality in patients with chronic kidney disease (CKD). The complex process of accelerated athero- and arteriosclerosis in CKD is associated with this phenomenon, where endothelial dysfunction (ED) is one of the initial steps. Hence, the early diagnosis of ED can potentially lead to early interventions which could result in a better outcome for these patients. Several methodologies have been developed for the diagnosis of ED. Laser Doppler flowmetry (LDF) enables us to study the microcirculation continuously in a non-invasive manner. In our review we would like to focus on different tests developed for LDF, like postocclusive reactive hyperaemia, local heating, iontophoresis, microdialysis or analysis of flowmotion. We would also like to summarize the available data in CKD with these methodologies to enlighten their perspectives in the clinical use on this patient population.

Entities:  

Keywords:  Chronic kidney disease; Endothelial dysfunction; Flowmotion; Iontophoresis; Laser Doppler flowmetry; Local heating; Microdialysis; Postocclusive reactive hyperaemia

Year:  2013        PMID: 24255889      PMCID: PMC3832914          DOI: 10.5527/wjn.v2.i3.77

Source DB:  PubMed          Journal:  World J Nephrol        ISSN: 2220-6124


  56 in total

Review 1.  Venous occlusion plethysmography in cardiovascular research: methodology and clinical applications.

Authors:  I B Wilkinson; D J Webb
Journal:  Br J Clin Pharmacol       Date:  2001-12       Impact factor: 4.335

Review 2.  Iontophoretic drug delivery.

Authors:  Yogeshvar N Kalia; Aarti Naik; James Garrison; Richard H Guy
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

3.  Blunted post-ischemic increase of the endothelial skin blood flowmotion component as early sign of endothelial dysfunction in chronic kidney disease patients.

Authors:  Marco Rossi; Adamasco Cupisti; Cinzia Di Maria; Fabio Galetta; Giuliano Barsotti; Gino Santoro
Journal:  Microvasc Res       Date:  2007-08-24       Impact factor: 3.514

Review 4.  Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.

Authors:  Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2006-04       Impact factor: 10.121

5.  Phenolic content of virgin olive oil improves ischemic reactive hyperemia in hypercholesterolemic patients.

Authors:  Juan Ruano; Jose Lopez-Miranda; Francisco Fuentes; Juan A Moreno; Cecilia Bellido; Pablo Perez-Martinez; Aquiles Lozano; Purificación Gómez; Yolanda Jiménez; Francisco Pérez Jiménez
Journal:  J Am Coll Cardiol       Date:  2005-10-24       Impact factor: 24.094

6.  Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.

Authors:  Frank Stam; Coen van Guldener; Annemarie Becker; Jacqueline M Dekker; Robert J Heine; Lex M Bouter; Coen D A Stehouwer
Journal:  J Am Soc Nephrol       Date:  2005-12-28       Impact factor: 10.121

7.  Microvascular endothelial function in obstructive sleep apnea: Impact of continuous positive airway pressure and mandibular advancement.

Authors:  Wojciech Trzepizur; Frédéric Gagnadoux; Pierre Abraham; Pascal Rousseau; Nicole Meslier; Jean-Louis Saumet; Jean-Louis Racineux
Journal:  Sleep Med       Date:  2009-01-14       Impact factor: 3.492

8.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

9.  Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease.

Authors:  B Payson Oberg; Elizabeth McMenamin; F Lee Lucas; Ellen McMonagle; Jason Morrow; T Alp Ikizler; Jonathan Himmelfarb
Journal:  Kidney Int       Date:  2004-03       Impact factor: 10.612

10.  Nitric oxide is not permissive for cutaneous active vasodilatation in humans.

Authors:  Brad W Wilkins; Lacy A Holowatz; Brett J Wong; Christopher T Minson
Journal:  J Physiol       Date:  2003-03-21       Impact factor: 5.182

View more
  4 in total

Review 1.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

2.  Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention Study.

Authors:  Kari Sørland; Miriam Kristine Sandvik; Ingrid Gurvin Rekeland; Lis Ribu; Milada Cvancarova Småstuen; Olav Mella; Øystein Fluge
Journal:  Front Med (Lausanne)       Date:  2021-03-22

3.  Effects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients.

Authors:  Shina Lee; Seung-Jung Kim
Journal:  Front Med (Lausanne)       Date:  2022-07-12

4.  Cardiovascular outcomes of Nephrotic syndrome in childhood (CVONS) study: a protocol for prospective cohort study.

Authors:  S K Patnaik; P Kumar; M Bamal; S Patel; M P Yadav; V Kumar; A Sinha; A Bagga; M Kanitkar
Journal:  BMC Nephrol       Date:  2018-04-03       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.